Evid Based Nurs 12:43 doi:10.1136/ebn.12.2.43
  • Treatment

Continuous glucose monitoring improved glycaemic control in pregnant women with diabetes and reduced infant macrosomia

H R Murphy

Dr H R Murphy, University of Cambridge, Cambridge, UK;


Does continuous glucose monitoring (CGM) improve glycaemic control in pregnant women with diabetes and reduce infant macrosomia?



randomised controlled trial. Current Controlled Trials ISRCTN84461581.





Follow-up period:

to delivery.


2 diabetes antenatal clinics in the UK.


71 pregnant women (mean age 31 y, mean gestational age 9 wks) who had type 1 diabetes (65% of women) or type 2 diabetes (35%) treated with insulin.


CGM plus standard antenatal care (n = 38) or standard care alone (n = 33). CGM was done every 4–6 weeks until 32 weeks of gestation. A subcutaneous sensor, attached to a portable monitor, was implanted by a nurse into the woman’s hip and worn for 5–7 days. The device recorded average tissue glucose concentrations every 5 minutes, but results were …

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article